Evidence map›Paper›PMID 38331433›Full record

ArticleJournal of medicinal chemistry2024

Probing the Mechanism of Action of Bis(phenolato) Amine (ONO Donor Set) Titanium(IV) Anticancer Agents.

Mustapha Musa, Mohammed Abid, Tracey D Bradshaw, David J Boocock, Clare Coveney, Stephen P Argent, Simon Woodward

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Early Transition Metal-Based Antitumor Complexes.Chemistry, an Asian journal · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mustapha MusaGSK Carbon Neutral Laboratories for Sustainable Chemistry, University of Nottingham, Triumph Road, Nottingham NG7 2TU, U.K.
Mohammed AbidDepartment of Chemistry, College of Science, University of Anbar, Anbarshire 31001, Iraq.
Tracey D BradshawBDI, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K.ORCID 0000-0001-8451-5092
David J BoocockSchool of Science and Technology, Nottingham Trent University, Clifton, Nottingham NG11 8NS, U.K.
Clare CoveneySchool of Science and Technology, Nottingham Trent University, Clifton, Nottingham NG11 8NS, U.K.
Stephen P ArgentSchool of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, U.K.ORCID 0000-0002-3461-9675
Simon WoodwardGSK Carbon Neutral Laboratories for Sustainable Chemistry, University of Nottingham, Triumph Road, Nottingham NG7 2TU, U.K.ORCID 0000-0001-8539-6232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for anticancer therapies that overcome metallodrug resistance while minimizing adverse toxicities is targeted, herein, using titanium coordination complexes. Octahedral titanium(IV)

Indexed as

Antineoplastic AgentsTitaniumAminesApoptosisCell Line, TumorHumansProteomicsAminesAntineoplastic AgentsTitanium

Identifiers

PMID38331433
PMCPMC10895680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.